Difference Between Loan License and Third Party Manufacturing
Understand the difference between loan license and third party manufacturing, including costs, MOQ, FSSAI compliance and quality control.
1. Understanding the Difference Between Loan License and Third Party Manufacturing
The primary difference between loan license and third party manufacturing is the nature of the manufacturing arrangement and the permissions under which production takes place. In a typical third party manufacturing arrangement, a brand engages an existing manufacturer to produce products under an agreed commercial and quality framework. In a loan licence arrangement, the applicant may be authorised to manufacture products at another licensee's facility under the applicable regulatory framework.
The distinction matters because a loan licence is not simply another name for third party manufacturing. The exact requirements depend on the product category, applicable law and relevant licensing authority.
Consider an entrepreneur planning to launch a whey protein powder brand in India. The entrepreneur has developed the brand name, identified a target audience and started speaking with gym owners. However, setting up a manufacturing unit would require substantial investment in equipment, premises, quality systems, staff and regulatory approvals.
The entrepreneur could approach an established manufacturer to produce the product under a third party arrangement. Alternatively, depending on the product category and applicable regulations, a loan licence route may be considered if the entrepreneur wants to operate under the relevant authorisation for manufacturing at another facility.
The second option should not be treated as automatically available for every nutraceutical product. The applicable legal framework needs to be checked first.
There are three questions worth asking before choosing either model.
Who holds the relevant manufacturing licence or authorisation?
Who is responsible for manufacturing, testing, documentation and batch release?
What level of regulatory and operational control does the brand want to maintain?
These questions are more useful than comparing quotations alone. A low manufacturing price may look attractive at the beginning, but unclear responsibilities can create problems when a product fails a quality check, packaging needs correction or a regulatory document is requested.
2. How Loan License Manufacturing Works in the Indian Nutraceutical Industry
Loan licence manufacturing involves obtaining the relevant permission to manufacture products using the facilities of an existing licensed manufacturer, where the applicable regulatory framework permits this arrangement.
The applicant does not necessarily own the manufacturing premises or equipment. Instead, production takes place at another facility under the applicable licence conditions and regulatory oversight.
The precise process varies by product classification. A conventional food supplement regulated under the Food Safety and Standards Authority of India framework may follow a different route from a drug regulated under the Drugs and Cosmetics Act. Products marketed as nutraceuticals should not automatically be assumed to follow pharmaceutical loan licence procedures.
For a business considering this route, the first task is to establish how the product is legally classified.
What does the process usually involve?
The business must identify the applicable product category, confirm the licensing requirements with the relevant authority and determine whether the proposed manufacturing facility and arrangement meet those requirements.
The parties may need to coordinate on product specifications, formulation, raw materials, manufacturing procedures, testing arrangements, labelling and the records required under the applicable rules.
For example, a company developing a vitamin and mineral supplement may need to check ingredient permissions, permitted quantities, product claims and labelling requirements before proceeding. A protein powder may require a different assessment depending on its ingredients, intended use and classification.
The paperwork cannot be treated as a formality to complete after production begins.
A common source of confusion is the assumption that having access to a licensed factory automatically gives a brand permission to manufacture any product there. It does not. The relevant authorisations, product scope and facility conditions must support the proposed activity.
When might a loan licence arrangement make sense?
This arrangement may be worth exploring for businesses that want a more formal manufacturing setup under the applicable regulatory framework and are prepared to handle the additional licensing, documentation and coordination involved.
However, the suitability of the route depends on the exact product and governing rules. Before investing in artwork, packaging materials or raw materials, the business should obtain clarity on the regulatory pathway.
3. How Third Party Manufacturing Works for Supplement Brands
Third party manufacturing is often a practical starting point for supplement brands that want to sell products without setting up their own production facility. The brand works with an established manufacturer that produces the agreed product under the applicable manufacturing licence and regulatory requirements.
The brand owner generally concentrates on product positioning, sales, distribution, packaging requirements and customer acquisition. The manufacturer handles the production activities covered by the agreement, including sourcing or processing raw materials, manufacturing, quality checks and packing, depending on the agreed scope.
For health supplements and nutraceuticals regulated by FSSAI, the brand must also ensure that the manufacturer's licence covers the relevant product category. FSSAI's licensing guidance specifically states that re-labellers must ensure their third party manufacturers hold a valid licence for manufacturing the same product.
Foscos+1
What does the process look like in practice?
Suppose a gym owner wants to launch a whey protein brand for customers who regularly purchase supplements. The owner has an established customer base but does not have the capital, technical staff or infrastructure to manufacture protein powder.
The owner approaches a third party manufacturer and discusses the proposed product, target price, flavour, protein specifications, packaging size and expected order quantity.
The manufacturer then evaluates whether the requested product can be produced using its existing capabilities or whether additional formulation work is required.
The process generally involves the following stages.
Product selection and formulation: The brand chooses an existing formulation or discusses a custom formulation with the manufacturer.
Commercial discussion: Both parties agree on the minimum order quantity, pricing, packaging, payment terms and expected production schedule.
Regulatory and label review: The product category, ingredients, permitted claims and labelling requirements are checked before production.
Manufacturing and testing: The product is manufactured according to the agreed specifications and subjected to the applicable quality checks.
Packing and dispatch: The finished product is packed, labelled and dispatched according to the agreed terms.
Not every product follows the same timeline. A ready formulation with standard packaging may move faster than a product requiring new flavour development, ingredient verification or customised packaging.
This is where a manufacturer's experience becomes relevant. A protein powder may taste acceptable during initial sampling but behave differently when produced at a larger scale. Sweetness, solubility, texture and the consistency of each batch need attention. Packaging must also protect the product from moisture and other conditions that could affect quality during storage and transport.
I still remember seeing cartons stacked in a warehouse during peak summer. Storage conditions are easy to overlook when everyone is focused on launching the product.
Does the brand need to own a manufacturing facility?
No. That is one of the main reasons businesses consider third party manufacturing.
However, not owning a factory does not mean the brand can ignore compliance. Depending on the business activities, the brand may need its own applicable FSSAI licence or registration, and its responsibilities as a marketer or re-labeller must be assessed correctly.
Brands should also agree on who approves the formulation, who arranges testing, how batch records are maintained, how complaints are handled and what happens if a batch fails to meet the agreed specifications.
For businesses exploring private label supplement manufacturing, third party manufacturing can provide a route to launch products without taking on the full operational burden of running a factory.
4. Key Differences Between Loan License and Third Party Manufacturing
The difference between loan license and third party manufacturing becomes clearer when the two arrangements are compared across licensing, production control, investment and day to day responsibilities.
One important point is that terminology can vary between the pharmaceutical and food supplement industries. A loan licence arrangement used for drugs should not automatically be applied to an FSSAI-regulated nutraceutical product. The legal classification determines which rules and permissions apply.
The following comparison describes the general distinction. The precise allocation of responsibilities must be confirmed for the product and regulatory framework concerned.
Comparison factor
Loan licence manufacturing
Third party manufacturing
Basic arrangement
The applicant obtains the relevant manufacturing licence or permission to use another eligible facility, where permitted
The brand engages a licensed manufacturer to produce the agreed product
Manufacturing facility
An existing facility is used under the applicable licence conditions
The manufacturer's facility is used under its applicable manufacturing authorisation
Regulatory involvement
The applicant may have additional licensing and compliance responsibilities
The brand and manufacturer fulfil their respective regulatory responsibilities
Initial investment
May involve licensing costs, documentation and additional coordination
Usually avoids the cost of establishing a factory and may require fewer initial regulatory arrangements
Production control
Can offer greater formal involvement, subject to the licence and agreement
Control is generally exercised through specifications, approvals and the manufacturing contract
Formulation
Depends on the approved product scope and agreed responsibilities
Can involve an existing formulation or a custom formulation, subject to feasibility and compliance
Production planning
Requires coordination with the host facility and compliance with licence conditions
Depends on the manufacturer's capacity, order commitments and production schedule
Documentation
May require additional licensing and facility-related documentation
Requires appropriate product, manufacturing, quality and commercial records
Best suited to
Businesses whose operating model justifies the additional regulatory involvement
Brands seeking an external manufacturing partner without operating their own facility
The difference between loan license and third party manufacturing is not simply a question of which option is cheaper. The business must consider the regulatory structure, the amount of control it needs and the resources available to manage the arrangement.
Which option is simpler to start with?
For many new supplement brands, third party manufacturing is easier to explore because the business can begin by discussing a product brief and commercial requirements with an established manufacturer. It does not automatically need to establish a separate loan licence arrangement.
That said, third party manufacturing still involves meaningful decisions. A brand selling a product under its own name should understand its labelling obligations, applicable licences, product specifications and quality responsibilities before placing an order.
A loan licence arrangement may be appropriate in a different set of circumstances, particularly where the applicable regulatory framework permits it and the business has a clear reason to take on the associated responsibilities.
A manufacturer should explain these distinctions rather than simply recommend the option that appears more profitable for the supplier.
5. Which Manufacturing Model Offers Better Control Over Production?
Control over production means different things to different businesses. One entrepreneur may want to approve every ingredient and flavour change. Another may be concerned mainly about consistent quality, timely dispatch and having enough stock for distributors.
The difference between loan license and third party manufacturing should therefore be evaluated against the type of control the business actually needs.
Control over formulation and ingredients
A brand planning to launch a specialised sports nutrition product may want a defined protein content, a particular sweetener system, a specific flavour profile and clear ingredient specifications.
With third party manufacturing, these requirements can be documented in a product specification and manufacturing agreement. The manufacturer then needs to produce the product in accordance with the agreed requirements and applicable regulations.
A loan licence arrangement may offer a different level of formal involvement, depending on the applicable authorisation and the contractual arrangement. However, it does not automatically guarantee complete control over every manufacturing decision.
The practical question is whether the brand has clear rights to approve changes, access relevant quality records and obtain the information needed to verify that the finished product meets its specifications.
Control over quality testing
For a protein powder, the brand should understand what the protein claim means and how it will be verified. Depending on the product and applicable standards, relevant checks may include protein content, microbiological quality, moisture and other product-specific parameters.
The parties should agree on the testing requirements, the laboratory arrangements where applicable, the records provided with each batch and the process for handling an unsatisfactory result.
Neither manufacturing model removes the need for proper quality controls. A loan licence does not automatically mean better testing, and third party manufacturing does not automatically mean less reliable testing. The actual quality system matters more than the name of the arrangement.
Control over production schedules and inventory
Consider a supplement brand that receives a large order from a distributor shortly before a promotional campaign. The brand needs fresh inventory, but its manufacturer is already handling several production orders.
In this situation, the manufacturing model alone will not guarantee priority. Capacity commitments, raw material availability, packaging lead times and written production schedules are what matter.
A brand should clarify the expected lead time, how changes to an order are handled and whether the manufacturer can support repeat orders as demand grows.
This is particularly important for custom formulations. If a product uses a specialised ingredient or a custom flavour system, the manufacturer may need additional time to source materials and validate the production process.
What about ownership of the formula and product specifications?
This is worth discussing before the first batch.
If a brand invests in a custom nutraceutical formulation, it should document who owns the formulation, what information can be shared, whether the manufacturer can reproduce it for another customer and what happens if the brand changes manufacturing partners.
These questions should be settled in writing. A loan licence does not by itself establish intellectual property ownership, just as a third party manufacturing agreement does not automatically transfer formula ownership to the brand.
For MGVS Lifesciences, businesses considering private label supplement manufacturing or custom nutraceutical formulation should begin with a clear product brief and a discussion about the required specifications, quality documentation, commercial terms and applicable regulatory pathway.
The practical decision is this: if the main objective is to launch a supplement brand without running a manufacturing facility, third party manufacturing is often the first option worth evaluating. If the business needs a different licensing structure and is prepared to manage its additional responsibilities, a loan licence arrangement may deserve consideration where legally available.
Before choosing, ask the manufacturer to explain exactly which licence applies to the product, who is responsible for each compliance requirement and what level of production control the agreement actually provides.
6. Investment, MOQ and Cost Differences Between Both Models
For a new nutraceutical brand, the first commercial discussion often comes down to three things: how much money is required to start, what minimum order quantity the manufacturer expects, and how much the finished product will cost.
The difference between loan license and third party manufacturing can affect the costs a business needs to plan for, but there is no fixed price difference that applies to every product. The formulation, packaging, testing requirements, regulatory route and production volume all influence the final calculation.
Where does the money go?
With third party manufacturing, a brand generally avoids the capital expenditure involved in establishing a production facility. Its initial budget may cover product development, samples, manufacturing, packaging, testing where separately charged, label design, applicable licences and registrations, and distribution.
A loan licence arrangement may involve additional expenses relating to licensing, documentation, regulatory coordination and the specific requirements of the host manufacturing facility. These costs depend on the applicable product category and the arrangement being considered.
Cost factor
Loan licence arrangement
Third party manufacturing
Factory setup
Usually not required if an existing facility is used
Not required by the brand
Licensing and documentation
May involve additional applicant and facility related requirements
Depends on the brand's activities and applicable licensing requirements
Product development
Depends on formulation and testing needs
Depends on whether an existing or custom formulation is selected
Minimum order quantity
Set by production feasibility and the arrangement
Set by the manufacturer, product and packaging requirements
Packaging
Depends on the agreed responsibilities
Depends on the agreed scope and packaging choice
Ongoing coordination
May involve additional licensing and facility coordination
Usually managed through the manufacturing agreement and order process
Is a lower MOQ always better?
Not necessarily. A low minimum order quantity can help a startup test demand without tying up too much working capital. However, the per-unit cost may be higher, and certain packaging materials or raw ingredients may have their own minimum purchase quantities.
Imagine a startup planning to launch a protein powder in two flavours. The owner wants a small initial batch because demand is not yet proven. If each flavour requires separate flavouring ingredients, packaging artwork and production preparation, splitting the order may increase costs or extend the timeline.
Sometimes clients focus on saving a small amount per unit while overlooking the cost of unsold stock, expiry risk and warehouse storage. That saving can disappear quickly.
For an established distributor with predictable sales, a larger order may make more commercial sense. For a new brand, preserving working capital and testing actual customer demand may be more important than negotiating the lowest quoted unit price.
Before accepting a quotation, ask for a clear cost breakdown covering the product, packaging, testing, taxes, freight, payment terms and any additional development charges. Also clarify whether the quoted price applies to the first order only or to repeat orders.
7. FSSAI Compliance, Quality Testing and Documentation Requirements
Regulatory compliance is one area where businesses should avoid making assumptions based on the manufacturing model alone. The difference between loan license and third party manufacturing does not determine all the legal requirements. The product's classification and the applicable regulations do.
In India, food supplements and nutraceuticals regulated as foods fall under the relevant FSSAI framework. Products that legally qualify as drugs may follow a different licensing and manufacturing route. The two should not be treated as interchangeable categories.
Start with the correct product classification
Before finalising the manufacturing arrangement, establish how the product is classified and which ingredients, quantities and claims are permitted.
For example, a vitamin supplement, a protein powder and a product containing specialised botanical ingredients may have different formulation and labelling considerations. The business should verify ingredient permissions, applicable standards and the proposed product claims before printing labels or placing a production order.
FSSAI's official website provides access to licensing information, regulations and food safety requirements.
FSSAI+1
What quality checks should a brand discuss?
Testing requirements depend on the formulation, product category, applicable standards and the risks associated with the ingredients. A suitable quality plan may include:
Raw material identity and relevant supplier documentation.
Verification of nutritional values and declared ingredient quantities.
Microbiological testing where applicable.
Testing for contaminants or other product specific risks.
Finished product checks against agreed specifications.
Shelf life and stability evidence appropriate to the product.
For a whey protein product, the brand should understand how the declared protein content is verified. It should not rely solely on the marketing specification or a supplier's verbal assurance.
Similarly, a capsule containing vitamins and minerals needs appropriate checks for its ingredients, dosage and finished product quality. Testing should be selected based on the product rather than copied from an unrelated supplement.
Packaging and label compliance
Packaging problems can delay a launch even after manufacturing is complete. A label may contain an unsupported health claim, an incorrect ingredient declaration, incomplete mandatory information or a product description that does not match the applicable category.
Before printing, check the requirements that apply to the product, including ingredient declarations, nutritional information, net quantity, batch details, date marking, manufacturer information, applicable licence numbers and required warnings or usage instructions.
The exact requirements vary by product. Legal and regulatory review should take place before the final packaging artwork is approved.
Brands should also establish how complaints, rejected batches, recalls and deviations will be handled. Quality documentation is useful only when the parties understand who maintains it, who reviews it and how it can be accessed when required.
8. Which Model Is Better for Startups, Established Brands and Distributors?
The best manufacturing arrangement depends on the business's stage, expected order volume and ability to manage regulatory responsibilities. A startup selling its first 500 or 1,000 units has different requirements from a distributor supplying multiple states or an established wellness company launching ten new products.
For nutraceutical startups
Third party manufacturing is often a sensible starting point for entrepreneurs who want to validate demand before committing significant capital.
A startup can begin with a focused product range, understand customer feedback and expand gradually. For example, a gym owner could launch a protein powder and creatine product before adding mass gainers, pre workout supplements or other sports nutrition products.
The important point is to confirm the manufacturer's actual MOQ, not just the minimum mentioned during an initial sales conversation. Ask whether the quantity applies separately to each flavour, pack size and product.
I might be wrong here, but this does not apply to every manufacturer. Some facilities are better equipped for small batches, while others are commercially suited to larger production runs.
A loan licence arrangement may be worth exploring if the startup has a specific regulatory or operational reason for using that structure. It should not be selected merely because it sounds like a more advanced manufacturing arrangement.
For established supplement brands
An established brand may have predictable sales, established distributors and a larger product portfolio. Its priorities may include consistent batch quality, reliable production schedules, custom formulations and better coordination between manufacturing and inventory planning.
At this stage, the question is not simply which model has the lowest initial cost. The business should examine its long term production requirements and the administrative work involved in each arrangement.
For example, a company selling several vitamin and mineral supplements may benefit from consolidating production with a capable manufacturing partner. Another company with a specific reason to maintain a different licensing structure may need to evaluate the loan licence route under the applicable regulations.
For distributors and private label businesses
Distributors often want to introduce products under their own brand without managing a factory. Third party manufacturing can be suitable for this model, provided the necessary product, licensing, labelling and quality requirements are met.
However, distributors should plan inventory carefully. Ordering too much stock before establishing demand can tie up working capital, particularly when products have a limited shelf life.
For doctors and wellness professionals
A doctor or wellness professional planning to launch a branded supplement should give particular attention to permitted claims, ingredient selection, dosage information and label compliance.
The product should be positioned within the applicable regulatory framework. It should not be marketed with unsupported claims about treating or curing diseases.
For most buyers, a useful decision rule is to start with the simplest legally appropriate manufacturing arrangement that meets their quality, commercial and regulatory needs. The complexity of the paperwork should be justified by a clear business requirement.
9. How MGVS Lifesciences Supports Nutraceutical Brands With Manufacturing Requirements
Choosing a manufacturing partner involves more than asking for a price list. The business needs to understand whether the proposed product is feasible, what specifications can be met, which documents are required and how production will be coordinated.
MGVS Lifesciences can be approached to discuss nutraceutical manufacturing requirements, including private label products, custom formulations and third party manufacturing, subject to the company's current capabilities and applicable regulatory permissions.
For a brand planning to enter the market, the initial discussion should cover five practical areas.
Product requirements. Identify whether the product is a protein powder, vitamin supplement, capsule, tablet or another nutraceutical product. Share the intended formulation, target customer, pack size and any specific ingredient requirements.
Commercial feasibility. Discuss MOQ, indicative pricing, packaging options, sample development and expected order volumes. If the product requires a custom flavour or specialised ingredient, clarify the additional development requirements before approving the budget.
Regulatory pathway. Establish the correct product classification and applicable licensing requirements. For products regulated as foods, verify the relevant FSSAI permissions and ensure the manufacturing arrangement is consistent with the applicable rules.
Quality expectations. Agree on the product specifications, relevant testing, batch documentation and procedures for addressing quality concerns. Brands should also clarify how changes to ingredients or packaging will be approved.
Production and dispatch. Discuss lead times, raw material availability, packaging procurement, payment milestones and shipping arrangements. These details are particularly important when launching products around seasonal demand or distributor commitments.
A useful first step is to prepare a short product brief before contacting MGVS Lifesciences. Include the proposed product, preferred formulation, target selling price, expected order quantity and intended sales market. This makes the initial discussion more specific and helps both parties identify the information still required.
You can visit the official website at MGVS Lifesciences to explore the company's manufacturing services and make an enquiry about your product requirements.
The aim should be to select a manufacturing arrangement that fits the business, rather than forcing the business into a model that creates unnecessary cost or compliance work.
10. Frequently Asked Questions About the Difference Between Loan License and Third Party Manufacturing
1. What is the main difference between loan license and third party manufacturing?
A loan licence arrangement generally involves obtaining the relevant authorisation to manufacture at another eligible facility, where permitted under the applicable law. Third party manufacturing usually involves engaging an existing licensed manufacturer to produce products under an agreed arrangement. The exact distinction depends on the product category and regulatory framework.
2. Is third party manufacturing better for nutraceutical startups?
It is often a practical option because startups can work with an established manufacturer without setting up their own production facility. However, the manufacturer must be suitable for the product, and the brand must fulfil its own applicable regulatory responsibilities.
3. Can a nutraceutical brand use a loan licence instead of third party manufacturing?
That depends on the product's legal classification and the applicable licensing framework. A loan licence route used for pharmaceutical products should not automatically be assumed to apply to food supplements regulated by FSSAI. Confirm the requirements with the relevant licensing authority before proceeding.
4. Which option has a lower minimum order quantity?
Neither model automatically offers a lower MOQ. Minimum quantities depend on the manufacturing facility, formulation, production equipment, packaging materials and commercial agreement. Request product specific quotations before deciding.
5. Does third party manufacturing require an FSSAI licence for the brand owner?
Depending on its activities, a brand owner obtaining food products from a third party manufacturer may need an appropriate FSSAI licence as a re-labeller. FSSAI's official guidance explains that re-labellers must ensure their third party manufacturers hold a valid manufacturing licence for the same product. The precise requirement should be confirmed for the business's activities.
Foscos+1
6. Who is responsible for product quality in third party manufacturing?
The manufacturer is responsible for carrying out manufacturing activities in accordance with its applicable licence, regulatory requirements and agreed specifications. The brand also needs to fulfil its own legal responsibilities for the product and its marketing activities. The agreement should clearly establish testing, batch release, complaint handling and recall procedures.
7. Can I launch a private label protein powder through third party manufacturing?
Yes, subject to the manufacturer's capabilities, the applicable product requirements and the necessary permissions. The brand should discuss protein specifications, flavour development, testing, packaging, MOQ and label compliance before placing an order.
8. Can I switch from third party manufacturing to a loan licence later?
A business may explore a different manufacturing arrangement as it grows, but the transition is not automatic. It requires an assessment of the applicable licensing framework, facility eligibility, product approvals where relevant, documentation and contractual obligations.
9. What documents should I request before selecting a manufacturer?
Ask for the applicable manufacturing licence, relevant product category permissions, available quality documentation, product specifications, testing arrangements and a written quotation. Depending on the product, you may also need ingredient documentation, batch records, shelf life information and label compliance review.
10. How should I choose between loan licence and third party manufacturing for MGVS Lifesciences?
Begin by identifying the product, intended sales market, expected order volume and the degree of manufacturing control you need. Then discuss the available manufacturing arrangement, applicable regulatory requirements, MOQ, testing and commercial terms with MGVS Lifesciences. Choose only after confirming that the proposed setup meets your business and compliance requirements.
Official references for further verification
For regulatory decisions, refer to the relevant official sources rather than relying solely on a manufacturer's explanation.
FSSAI health supplements and nutraceutical standards: Official FSSAI standards
Food Safety Compliance System: FoSCoS licensing portal
FSSAI regulations and amendments: Food safety regulations
Food Product Identity Verification System: Official product classification resource
Before finalising a manufacturing agreement, ask one question that is easy to overlook: if your first product sells well and you need to double the order quantity, can the same arrangement support that growth without creating new regulatory or production problems? The answer is worth understanding before you commit your money.